Altwal Johnny, Griffin Lynn, Martin Tiffany Wormhoudt
Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Colorado, Fort Collins, US.
Advanced Animal Cancer Imaging LLC, Victoria, British Columbia, Canada.
Vet Comp Oncol. 2025 Mar;23(1):116-122. doi: 10.1111/vco.13037. Epub 2025 Jan 2.
Body composition measurements (BCM), obtained via computed tomography (CT), have been used as predictors of survival, tumour recurrence, and post-surgical infections in human oncology. There are no reports on using BCM to predict outcomes of dogs with cancer. Elevated BCM is hypothesised to place extra stress on bones weakened by cancer. Pathologic fracture following stereotactic body radiation therapy for canine appendicular osteosarcoma (OSA) frequently results in limb amputation or euthanasia. Additional tools are needed to better predict the risk of fracture development. Our objectives were to determine if any relationships could be identified between BCM and the occurrence of a pathologic fracture and/or survival time in dogs with naturally occurring OSA. Forty-seven dogs with a confirmed OSA and whole-body CT pre-SBRT were included. Several BCM were evaluated, including abdominal volume, visceral adipose tissue volume, whole-body volume, whole-body adipose tissue volume, normalised cross-sectional area of the epaxial muscles at the mid-body of the 13th thoracic vertebra, and attenuations of adipose tissue and epaxial muscles. No BCMs were correlated with survival time. The volume of the entire body (cm) was significantly positively associated with development of a fracture. No other BCM were correlated with the development of a fracture. The volume of the abdomen (cm) among our patient subset was positively correlated with the volume of the entire body, and the volume of visceral adipose tissue (cm) was positively correlated with the total body volume of adipose tissue (cm). Additional research is needed to verify whether these findings are replicable in larger sample sizes and in prospective settings.
通过计算机断层扫描(CT)获得的身体成分测量(BCM)已被用作人类肿瘤学中生存、肿瘤复发和术后感染的预测指标。目前尚无关于使用BCM预测犬类癌症预后的报道。BCM升高被认为会给因癌症而变弱的骨骼带来额外压力。犬类附肢骨肉瘤(OSA)立体定向体部放射治疗后的病理性骨折常导致肢体截肢或安乐死。需要更多工具来更好地预测骨折发生风险。我们的目标是确定在自然发生OSA的犬类中,BCM与病理性骨折的发生和/或生存时间之间是否存在任何关联。纳入了47只确诊为OSA且在立体定向体部放射治疗前进行了全身CT检查的犬。评估了多个BCM,包括腹部体积、内脏脂肪组织体积、全身体积、全身脂肪组织体积、第13胸椎中体处轴上肌的标准化横截面积以及脂肪组织和轴上肌的衰减。没有BCM与生存时间相关。全身体积(cm)与骨折的发生显著正相关。没有其他BCM与骨折的发生相关。我们患者亚组中的腹部体积(cm)与全身体积正相关,内脏脂肪组织体积(cm)与全身脂肪组织体积(cm)正相关。需要进一步研究以验证这些发现在更大样本量和前瞻性研究中是否可重复。
Vet Comp Oncol. 2009-3
Cancers (Basel). 2023-1-12
Front Vet Sci. 2021-10-1